OrganoClick AB Statistics

Total Valuation

OrganoClick AB has a market cap or net worth of SEK 192.31 million. The enterprise value is 275.74 million.

Market Cap	192.31M
Enterprise Value	275.74M

Important Dates

The last earnings date was Tuesday, May 6, 2025.

Earnings Date	May 6, 2025
Ex-Dividend Date	n/a

Share Statistics

OrganoClick AB has 98.12 million shares outstanding. The number of shares has increased by 0.14% in one year.

Current Share Class	98.12M
Shares Outstanding	98.12M
Shares Change (YoY)	+0.14%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	33.74%
Owned by Institutions (%)	17.60%
Float	50.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.55
PB Ratio	5.64
P/TBV Ratio	440.07
P/FCF Ratio	n/a
P/OCF Ratio	54.62
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-14.23
EV / Sales	2.22
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-743.23

Financial Position

The company has a current ratio of 0.69, with a Debt / Equity ratio of 2.21.

Current Ratio	0.69
Quick Ratio	0.29
Debt / Equity	2.21
Debt / EBITDA	94.25
Debt / FCF	-203.49
Interest Coverage	-2.10

Financial Efficiency

Return on equity (ROE) is -42.35% and return on invested capital (ROIC) is -7.34%.

Return on Equity (ROE)	-42.35%
Return on Assets (ROA)	-4.68%
Return on Invested Capital (ROIC)	-7.34%
Return on Capital Employed (ROCE)	-19.09%
Revenue Per Employee	3.11M
Profits Per Employee	-484,350
Employee Count	40
Asset Turnover	0.73
Inventory Turnover	2.50

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -39.51% in the last 52 weeks. The beta is 1.14, so OrganoClick AB's price volatility has been higher than the market average.

Beta (5Y)	1.14
52-Week Price Change	-39.51%
50-Day Moving Average	2.21
200-Day Moving Average	2.67
Relative Strength Index (RSI)	39.46
Average Volume (20 Days)	46,647

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, OrganoClick AB had revenue of SEK 124.45 million and -19.37 million in losses. Loss per share was -0.20.

Revenue	124.45M
Gross Profit	29.60M
Operating Income	-12.80M
Pretax Income	-18.18M
Net Income	-19.37M
EBITDA	-7.41M
EBIT	-12.80M
Loss Per Share	-0.20

Full Income Statement

Balance Sheet

The company has 401,000 in cash and 75.50 million in debt, giving a net cash position of -75.10 million or -0.77 per share.

Cash & Cash Equivalents	401,000
Total Debt	75.50M
Net Cash	-75.10M
Net Cash Per Share	-0.77
Equity (Book Value)	34.11M
Book Value Per Share	0.26
Working Capital	-34.58M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.52 million and capital expenditures -3.89 million, giving a free cash flow of -371,000.

Operating Cash Flow	3.52M
Capital Expenditures	-3.89M
Free Cash Flow	-371,000
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross margin is 23.78%, with operating and profit margins of -10.28% and -15.57%.

Gross Margin	23.78%
Operating Margin	-10.28%
Pretax Margin	-14.61%
Profit Margin	-15.57%
EBITDA Margin	-5.95%
EBIT Margin	-10.28%
FCF Margin	n/a

Dividends & Yields

OrganoClick AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.14%
Shareholder Yield	n/a
Earnings Yield	-10.07%
FCF Yield	-0.19%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

OrganoClick AB has an Altman Z-Score of -0.77. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.77
Piotroski F-Score	n/a